The DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessAbstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Cited by
Items 401–500 of 725
Chen, F., Zhang, Q., Deng, X., Zhang, X., Chen, C., Lv, D., Li, Y., Li, D., Zhang, Y., Li, P., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1500057 · Cited by 16
“Disrupted correlation of DNA methylation and CpG density has been reported in various cancers [29], characterized by hypermethylation in transcription start site (TSS) associated CGIs, which have high CpG density and usually low methylation in normal tissues [26,30].”
BackgroundNowak, E., Poczęta, M., Bieg, D., & Bednarek, I. A. (2017) · Ginekologia Polska · doi:10.5603/gp.a2017.0099 · Cited by 15
“pl/ginekologia_polska the inactivation of certain tumor suppressor genes, which is observed in different cancer types [5].”
BackgroundCould the Epigenetics of Eosinophils in Asthma and Allergy Solve Parts of the Puzzle?
Bélanger, É., & Laprise, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168921 · Cited by 17
“Methylated DNA can promote the recruitment of histone and chromatin modifying complexes [46,47] or inhibit transcription by repressing the recruitment of DNA-binding proteins [48].”
BackgroundInsight into the physiological and pathological roles of USP44, a potential tumor target (Review)
Lou, Y., Ye, M., Xu, C., & Tao, F. (2022) · Oncology Letters · doi:10.3892/ol.2022.13575 · Cited by 13
“Promoter hypermethyl‑ ation is an important mechanism for the epigenetic silencing of tumor suppressor genes (101,102).”
Han, Y. K., Park, H. Y., Park, S.-G., Hwang, J. J., Park, H. R., & Yi, J. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314624 · Cited by 13
“An aberrant DNA methylation pattern is a known hallmark of cancer cells [5], with DNA methylation abnormalities associated with tumor suppressor gene (TSG) silencing, leading to cancer progression.”
BackgroundBreast cancer: mechanisms involved in action of phytoestrogens and epigenetic changes.
Dagdemir, A., Durif, J., Ngollo, M., Bignon, Y., & Bernard-Gallon, D. J. (2013) · PubMed · Cited by 22
Demethylation treatment restores erectile function in a rat model of hyperhomocysteinemia
Dai, Y., Zhang, Z., Zhu, L., Jiang, H., Chen, H., & Chen, Y. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.163271 · Cited by 13
Minárovits, J., & Niller, H. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3 · Cited by 13
“212 The Role of DNMT3B Mutations in the Pathogenesis of ICF Syndrome The de novo DNMTs are highly expressed in embryonic tissue and stem (ES) cells and become downregulated in differentiated cells (Esteller 2007 ) .”
BackgroundThe quest for an effective and safe personalized cell therapy using epigenetic tools
Brevini, T., Pennarossa, G., Manzoni, E. F. M., Gandolfi, C. E., Zenobi, A., & Gandolfi, F. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0283-5 · Cited by 16
Wang, Y., Liu, D., Jin, X. K., Song, H., & Lou, G. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.11.002 · Cited by 13
Stubendorff, B., Wilhelm, K., Posselt, K., Catto, J. W. F., Hartmann, A., Bertz, S., Fuessel, S., Novotný, V., Toma, M. I., Gajda, M. R., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-02829-4 · Cited by 13
Metastasis of Colorectal Cancer
Beauchemin, N., & Huot, J. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8 · Cited by 16
Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate
Wang, Z., Huang, R., Wang, H., Peng, Y., Fan, Y., Feng, Z., Zeng, Z., Ji, Y., Wang, Y., & Lu, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.842975 · Cited by 13
“However, things in nature are often not that simple, and Smith et al. gave an overview of promoter DNA hypermethylation that guides gene expression activation, although it seems counterintuitive (Smith et al., 2020).”
BackgroundInfluentialZhang, Y., Chen, K., Tang, S. C., Cai, Y., Niibori-Nambu, A., See, Y. X., Fu, C., Raju, A., Lebeau, B., Ling, Z., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01391-7 · Cited by 19
Reversing epigenetic mechanisms of drug resistance in solid tumors using targeted microRNA delivery
Berman, M., Mattheolabakis, G., Suresh, M., & Amiji, M. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1178236 · Cited by 13
“It is important to note that almost half of the miRNA sequences are associated with CpG islands, thus, just as their expression can exert influence over the machinery of epigenetic modifications, their expression is amenable to those same epigenetic mechanisms.[133,134] This complexity becomes increasingly clear as we…”
BackgroundIntegrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer
Liu, C., Rohart, F., Simpson, P. T., Khanna, K. K., Ragan, M. A., & Cao, K. L. (2016) · Scientific Reports · doi:10.1038/srep34000 · Cited by 12
Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer
Szczyrek, M., Grenda, A., Kuźnar-Kamińska, B., Krawczyk, P. A., Sawicki, M., Batura‐Gabryel, H., Mlak, R., Szudy‐Szczyrek, A., Krajka, T., Krajka, A., et al. (2021) · Cancers · doi:10.3390/cancers13236139 · Cited by 13
“Theoretically, hypermethylation of promoters causes gene silencing, while demethylation leads to their activation [13,14].”
BackgroundDDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
Yuan, M., Xu, J.-Y., Cao, S.-G., & Sun, S.-S. (2022) · BMC Immunology · doi:10.1186/s12865-022-00533-0 · Cited by 10
Hergalant, S., Saurel, C., Divoux, M., Rech, F., Pouget, C., Godfraind, C., Rouyer, P., Lacomme, S., Battaglia-Hsu, S.-F., & Gauchotte, G. (2022) · Cancers · doi:10.3390/cancers14246227 · Cited by 12
“One such hit is the developmentally targeted epigenetic silencing by polycomb repressor complex 2; although it is difficult to extrapolate these previous results to meningiomas, this silencing is well-documented in brain cancers [31,32].”
BackgroundEkim, M., Caner, V., Büyükpınarbaşılı, N., Tepeli, E., Elmas, L., & Bağcı, G. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0211 · Cited by 12
“It has been reported that the frequency of promoter methylation of MGMT was increased in a variety of human cancers, including lung cancer (Pegg, 2000; Esteller, 2007; Jacinto and Esteller, 2007).”
Chromatin analysis of occluded genes
Lee, J. H., Gaetz, J., Bugarija, B., Fernandes, C. J., Snyder, G. E., Bush, E., & Lahn, B. T. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp188 · Cited by 14
Wang, W. T., Auer, P. L., Zhang, T., Spellman, S. R., Carlson, K.-S., Nazha, A., Bolon, Y., & Saber, W. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.04.027 · Cited by 15
The Role of Surgery in Cancer Prevention
Jatoi, I., Benson, J. R., Liau, S., Chen, Y., Cisco, R. M., Norton, J. A., Moley, J. F., Khalifeh, K. W., & Choti, M. A. (2010) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2010.06.002 · Cited by 14
A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation
Tierling, S., Schuster, M., Tetzner, R., & Walter, J. (2010) · Epigenetics & Chromatin · doi:10.1186/1756-8935-3-12 · Cited by 12
“Such epigenetic changes are widely used as molecular markers in tumor cell diagnostics [1-3].”
BackgroundEpigenetic pharmacology in aging: from mechanisms to therapies for age-related disorders
Yu, H., Feng, T., Zhang, C., Jiao, Z., Fan, W., Jiang, R., Kong, D., & Li, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1699296 · Cited by 15
Giraffe: A tool for comprehensive processing and visualization of multiple long-read sequencing data
Liu, X., Shao, Y., Guo, Z., Ni, Y., Sun, X., Leung, A. Y. H., & Li, R. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.08.003 · Cited by 11
“The methylation proportion in eukaryotes is associated with the strength of promoter activity and downstream protein expression, which has significant implications for exploring the mechanisms underlying various diseases [20,21].”
BackgroundIdentification of BMP2 as an epigenetically silenced growth inhibitor in rhabdomyosarcoma
Wolf, S., Hagl, B., & Kappler, R. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2312 · Cited by 11
Saikia, S., Rehman, A. U., Barooah, P., Sarmah, P., Bhattacharyya, M., Deka, M., Deka, M., Goswami, B., Husain, S. A., & Medhi, S. (2017) · Tumor Biology · doi:10.1177/1010428317701630 · Cited by 11
Pehli̇van, M., Çalışkan, C., Yüce, Z., & Sercan, H. O. (2017) · Tumor Biology · doi:10.1177/1010428317701654 · Cited by 11
Gillio‐Tos, A., Fiano, V., Zugna, D., Vizzini, L., Pearce, N. E., Delsedime, L., Merletti, F., & Richiardi, L. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0032-9 · Cited by 11
Expression of bone morphogenetic protein 6 in non‑small cell lung cancer and its significance
Xiong, W., Wang, L., & Yu, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.9781 · Cited by 13
“Hypermethylation may inhibit gene transcription and reduce the protein expression, and can result in the inactivation of tumor suppressor genes (24).”
BackgroundColorectal carcinogenesis via serrated route
Stefanius, K. (2011) · Cited by 11
Taylor, K., Wheeler, R. J., Singh, N., Vosloo, D., Ray, D. W., & Sommer, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-23309-2 · Cited by 12
The DNA methylation landscape of five pediatric-tumor types
Parker, A., Quinteros, B., & Piccolo, S. (2022) · PeerJ · doi:10.7717/peerj.13516 · Cited by 12
“On the other hand, increased methylation levels of a tumor suppressor gene could cause lower gene expression and prevent it from performing regulatory functions (Esteller, 2007).”
BackgroundXu, Y., Tang, Q., Ding, N., Zhang, T., & Luo, H. (2023) · PeerJ · doi:10.7717/peerj.15476 · Cited by 13
“It is well-established that aberrant DNA methylation, including hypermethylation of CpG islands in gene promoters, contributes to the silencing of tumor suppressor genes in cancer ( Baylin, 2001 ; Esteller, 2002 , 2007 ).”
BackgroundCancer-retina antigens — A new group of tumor antigens
Golovastova, M. O., Bazhin, A. V., & Philippov, P. P. (2014) · Biochemistry (Moscow) · doi:10.1134/s000629791408001x · Cited by 10
“These changes can be hypermethylation in the promoter region of tumor suppressor genes leading to their silencing or by hypomethylation in this region of other genes leading to their activation [44 47].”
BackgroundBarua, C. C., & Yasmin, N. (2018) · Journal of Natural Products and Resources · doi:10.30799/jnpr.058.18040103 · Cited by 10
“In cancer cells, the control of hypermethylation of tumour-suppressor genes on CpG islands is deregulated which results in gene silencing and inactivation of tumour-suppressor genes [42].”
BackgroundShu, X., Shu, S., Zhai, Y., Zhu, L., & Ouyang, Z. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4369 · Cited by 10
“…transcription and expression during palatogenesis are orchestrated by a variety of cis -acting elements, and DNA methylation of these elements can repress mRNA transcription, for example, methylation of a gene promoter, enhancer, and silencer (Esteller, 2007; Jones, 2012; Ziller et al. , 2013).”
Effects of deranged metabolism on epigenetic changes in cancer
Chandra, V., & Hong, K. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0561-3 · Cited by 12
“Promoter CpG island methylation-affected genes in cancer are involved in several important cellular pathways such as DNA repair (hMLH1, MGMT, WRN, and BRCA1), vitamin response (RARB2 and CRBP1), Ras signaling (RASSFIA and NOREIA), cell-cycle control (p16INK4a, p15INK4b, and RB), the p53 network (p14ARF, TP73, and HIC-…”
BackgroundDNA Methylation Alterations in Human Cancers
Wang, S., & Wu, W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00005-4 · Cited by 14
An Unbiased Predictive Model to Detect DNA Methylation Propensity of CpG Islands in the Human Genome
Yalcin, D., & Otu, H. H. (2020) · Current Bioinformatics · doi:10.2174/1574893615999200724145835 · Cited by 11
Computational Analysis and Integration of MeDIP-seq Methylome Data
Wilson, G. A., & Beck, S. (2016) · InTech eBooks · doi:10.5772/61207 · Cited by 11
“promoters can lead to aberrant expression of oncogenes, whilst in contrast hypermethylation at specific island or shore sites can lead to transcriptional inactivation of genes involved in pathways such as DNA repair and apoptosis [2, 13].”
BackgroundZhang, Y., Xu, H., Shen, Y., Gong, Z., & Xiao, T. (2015) · Europe PMC (PubMed Central) · Cited by 9
Agrawal, K., Das, V., Otmar, M., Krečmerová, M., Džubák, P., & Hajdúch, M. (2016) · Cytometry Part A · doi:10.1002/cyto.a.23004 · Cited by 8
“ases (DNMTs) as the key target for DNA hypermethylation (5).”
BackgroundHIC1 and RassF1A Methylation Attenuates Tubulin Expression and Cell Stiffness in Cancer
Chen, C., He, B.-C., Chen, Y.-L., Lee, K., Tung, C.-H., Hsu, C., Lin, P.-Y., Chu, P., Leu, Y., Fu, W.-E., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102884 · Cited by 10
“DNA methylation is an epigenetic change inherited in somatic lineages [5] that dominantly silences the associated genes [6,7].”
BackgroundGorenjak, V., Vance, D. R., Dadé, S., Stathopoulou, M. G., Doherty, L., Xie, T., Murray, H. A., Masson, C., Lamont, J. V., FitzGerald, P. S., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00874-w · Cited by 9
“aged to relate individual CpGs with cardiovascular diseases [3], cancer [4] and other pathologies [5, 6].”
BackgroundOhashi, R., Umezu, H., Sato, A., Abé, T., Kondo, S., Daigo, K., Sato, S., Hara, N., Miyashita, A., Ikeuchi, T., et al. (2020) · Cells · doi:10.3390/cells9112409 · Cited by 9
“The CpG island methylation level at the promoters of tumor suppressor genes is widely known to contribute to tumorigenesis and tumor progression in many types of cancer by changing the promoter activity [55].”
BackgroundMielcarek-Kuchta, D., Paluszczak, J., Seget, M., Kiwerska, K., Biczysko, W., Szyfter, K., & Szyfter, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-1958-1 · Cited by 10
The prognostic value of UHRF-1 and p53 in gastric cancer
Babacan, N., Eğilmez, H. R., Yücel, B., Ilknur, P., ŞEKER, M. M., Kaçan, T., Bahçeci, A., Cihan, Ş., Akinci, B., Eriten, B., et al. (2016) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.173755 · Cited by 9
“Epigenetic silencing of tumor suppressor genes is a hallmark in human cancers affecting multiple cellular pathways, such as cell signaling, adhesion and invasion, cell cycle, angiogenesis, DNA repair, and apoptosis.[4,5] Epigenetic alterations contribute significantly to the development and progression of gastric canc…”
BackgroundSun, N., Zhang, J., Zhang, C., Shi, Y. X., Zhao, B., Jiao, A., & Chen, B. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9441 · Cited by 9
Oncological Ligand-Target Binding Systems and Developmental Approaches for Cancer Theranostics
Jeevanandam, J., Sabbih, G. O., Tan, K. X., & Danquah, M. K. (2021) · Molecular Biotechnology · doi:10.1007/s12033-020-00296-2 · Cited by 9
“CpG promoter is an ideal biomarker as it influences all cellular pathways with a cancer-type specific profile and it is associated with genes such as tumor suppressor, microRNAs, and DNA repair genes with growth inhibitory effects [41].”
BackgroundThe Role of Epigenetic Changes in Ovarian Cancer: A Review
Qazi, S., Sharma, A. K., & Raza, K. (2021) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-021-00505-z · Cited by 10
Endocrine-Disrupting Activity of Xenobiotics in Aquatic Animals
Lata, P., Hajam, Y. A., Kumar, R., & Rai, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-1214-8_2 · Cited by 11
The Ambiguous Role of HMGB1 Across the Hallmarks of Aging: A Narrative Review
Ning, M., Liang, Y., Zhang, L., Wang, F., & He, L. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s550572 · Cited by 8
“45 Epigenetic modifiers further influence HMGB1-mediated immune modulation by altering histone acetylation and DNA methylation patterns.”
Saraiva-Esperón, U., Ruibal, Á., & Herranz, M. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.10.043 · Cited by 8
“One of the most common lesions in cancer is the transcriptional repression of tumor suppressor genes by promoter CpG island hypermethylation [7].”
BackgroundKasai, H., Kawai, K., & Li, Y. (2011) · Genes and Environment · doi:10.3123/jemsge.33.61 · Cited by 8
Identification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis
Okuchi, Y., Imajo, M., Mizuno, R., Kamioka, Y., Miyoshi, H., Taketo, M. M., Nagayama, S., Sakai, Y., & Matsuda, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162300 · Cited by 9
Community detection from genomic datasets across human cancers
Haq, N. F., & Wang, Z. J. (2016) · IEEE Global Conference on Signal and Information Processing · doi:10.1109/globalsip.2016.7906021 · Cited by 8
“Analysis of different cancer types has shown that tumors originating from the same organ can significantly vary across subjects [3], whereas similar genomic alteration patterns can be observed across tumors originating from different tissues [6].”
BackgroundGiri, A. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.620811 · Cited by 9
“Further, ETV4 expression showed a negative correlation with promoter methylation (Figure 1E) suggesting that DNA methylation mediates expression by hindering transcription factor binding (Esteller, 2007).”
BackgroundCorrelation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma
Zhao, F., Zhu, S., Fang, J., Dong, H., & Zhu, C. (2023) · Head & Neck · doi:10.1002/hed.27377 · Cited by 8
“Overall hypomethylation and local hypermethylation are constant features of the cancer genome.(10,11) p16INK4A and MLH1 show hypermethylation in many cancers, including thyroid cancer(12,13); the sodium iodide transporter protein gene (SLC5A5 or NIS) is also specifically hypermethylated in thyroid cancer.”
BackgroundДарий, М. В., Rakhimova, A., Tashlitsky, V. N., Kostyuk, S. V., Veiko, N. N., Ivanov, A. A., Zhuze, A. L., & Gromova, E. S. (2013) · Molecular Biology · doi:10.1134/s0026893313020040 · Cited by 8
“Hypermethylation of CpG islands in the promoter regions of tumor suppressor genes is characteristic of cancer cells [12].”
BackgroundCheng, Y. (2012) · InTech eBooks · doi:10.5772/1337 · Cited by 10
Deciphering the DNA methylation landscape of colorectal cancer in a Korean cohort
Lim, S.-B., Joe, S., Kim, H.-J., Lee, J. L., Park, I. J., Yoon, Y. S., Kim, C. W., Kim, J.-H., Kim, S., Lee, J.-Y., et al. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0106 · Cited by 7
“These findings are consistent with those of previous studies showing that DNA hypermethylation in promoter CpG islands leads to tumor suppressor gene silencing, thereby contributing to carcinogenesis (6, 7).”
BackgroundResultPolycomb group proteins in hematopoietic stem cell aging and malignancies
Klauke, K., & de Haan, G. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0857-0 · Cited by 12
“Intriguingly, both genome-wide DNA hypomethylation and aberrant promoter hypermethylation are also epigenetic hallmarks of cancer [36, 37], which will be discussed further in this review.”
BackgroundComprehensive Epigenetic Analysis of the Signature Genes in Lung Adenocarcinoma
Zhang, Y., Zhao, W., & Zhang, J. (2017) · Epigenomics · doi:10.2217/epi-2017-0023 · Cited by 7
Yi, L., Luo, P., & Zhang, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28904 · Cited by 7
“Studies have delineated that abnormal methylation of tumor suppressor genes (TSGs) affects transcriptional activity; particularly, the hypermethylation of TSGs leads to a loss of function, thus inducing tumorigenesis.(8,9) Alvarez et al(10) showed that the loss of expression of RASSF1A and SLIT2 in breast cancer was a…”
BackgroundSadaf, S., Akhter, N., Alharbi, R., Sindi, A. A. A., Najm, M. Z., Alhumaydhi, F. A., Khan, M. A., Deo, S. V. S., & Husain, S. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.781400 · Cited by 7
“The finding depicts a strong association between promoter hyper-methylation and mRNA expression in deactivating or down-regulating the possible role of FOXP3 in the suppression of breast cancer (Esteller, 2007; Li et al., 2007).”
BackgroundSteinritz, D., & Thiermann, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-20790-2_149-1 · Cited by 7
Epigenetic markers in human gliomas: prospects for therapeutic intervention
Hesson, L. B., Krex, D., & Latif, F. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.10.1475 · Cited by 7
Epigenetic epidemiology of age-related diseases
Vaiserman, A. M., Voitenko, V. P., & Mekhova, L. (2011) · Russian Journal of Developmental Biology · doi:10.1134/s1062360411010127 · Cited by 18
“…that is determined after fertilization and can be modified only by mutations, the epigenetic labels are quite dynamic and extremely sensitive to a number of stimuli, thus being modifiable throughout a lifetime (Fraga et al., 2005a, b, 2007; Fraga and Esteller, 2007; Bjornsson et al., 2008;).”
BackgroundKordi-Tamandani, D. M., Hemati, S., Davani, S. K., & Arbabi, F. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12808 · Cited by 7
“indicate the roles of epigenetic changes and tumor-suppressor silencing through promoter hypermethylation in GC [2].”
BackgroundIoannou, A. K., Alexiadou, D. K., Kouidou, S., Girousi, S. T., & Voulgaropoulos, A. (2009) · Electroanalysis · doi:10.1002/elan.200900274 · Cited by 7
DNA demethylation and cancer metastasis: therapeutic implications
Szyf, M. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.5.519 · Cited by 7
“Second is the methylation of a long list of critical genes with tumor suppressor functions (for a review see [4] ); and third is the observation that overexpression of DNMT1 and DNMT3B could lead to hypermethylation of several genes and cellular transformation in cell culture [38] and in vivo [24] .”
BackgroundThe epigenetic regulation of HsMar1, a human DNA transposon
Renault, S., Genty, M., Gabori, A., Boisneau, C., Esnault, C., de Bernonville, T. D., & Augé‐Gouillou, C. (2019) · BMC Genetics · doi:10.1186/s12863-019-0719-y · Cited by 7
Kim, M., Lee, E., Zang, D. Y., Kim, H.-J., Kim, H. Y., Han, B., Kim, H.-S., Kang, H. J., Hwang, S., & Lee, Y. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-57919-6 · Cited by 7
Gao, C., Qiao, T., Yuan, S., & Zhuang, X. (2021) · Cancer Management and Research · doi:10.2147/cmar.s305452 · Cited by 7
“Studies have shown that epigenetic changes of DNA methylation and histone modification affect tumor development and treatment.(17) It is believed that DNA methyltransferase could inhibit transcription of target genes by forming transcription repressors with histone methyltransferase at promoter region.”
BackgroundColeman, W. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00004-3 · Cited by 11
Methylation profile as a new tool for classification of hepatocellular carcinoma
Perret, C. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.015 · Cited by 7
“Two main modifications have been described in tumors, a genome wide DNA hypomethylation that might contribute to the generation of chromosomal instability, the reactivation of transposable elements or the loss of imprinting, and the hypermethylation of the CpG islands in the promoter regions of tumor suppressor genes…”
Liu, X., Ni, Y., Wang, D., Ye, S., Yang, M., Sun, X., Leung, A. Y. H., & Li, R. (2023) · Scientific Data · doi:10.1038/s41597-023-02431-5 · Cited by 7
“For example, hypermethylation of tumor suppressor genes can lead to their silencing, promoting cancer development 13 .”
BackgroundEpigenetic modifications in drug‐induced liver injury: A systematic review
Santos‐Fernández, R. L. D. L., Segovia‐Zafra, A., Paz‐López, G., Matilla‐Cabello, G., Niu, H., Álvarez‐Álvarez, I., Stephens, C. M., Gonzalez-Jimenez, A., Lucena, M. I., Andrade, R. J., et al. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70053 · Cited by 7
Epigenetic regulation of ferroptosis in gastrointestinal cancers (Review)
Gong, L., Wu, L., Zhao, S., Xiao, S., Chu, X., Zhang, Y., Li, F., Li, S., Yang, H., & Jiang, P. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5534 · Cited by 7
DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
Thomas, N., García-Prieto, C. A., Dreval, K., Hilton, L. K., Abramson, J. S., Bartlett, N. L., Bethony, J., Bowen, J., Bryan, A. C., Casper, C., et al. (2025) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0240 · Cited by 10
“Specifically, changes to promoters and other regulatory regions can influence the expression of tumor suppressor genes (11, 12).”
Pereira, N. B., do Carmo, A. C. D. M., Campos, K., Costa, S. F. D. S., Diniz, M. G., Gomez, R. S., & Gomes, C. C. (2017) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2017.08.011 · Cited by 7
Ganesh, D., Dafar, A., Niklasson, J., SANDBERG, I., Braz‐Silva, P. H., Sapkota, D., Öhman, J. N., Giglio, D., & Hasséus, B. (2023) · Anticancer Research · doi:10.21873/anticanres.16302 · Cited by 8
DNA Methylation in Neurodegenerative Disorders
Xu, Z., & Li, X. (2012) · Current Geriatrics Reports · doi:10.1007/s13670-012-0026-1 · Cited by 8
Daugaard, I., Hussmann, D., Kristensen, L., Kristensen, T. K., Kjeldsen, T. E., Nyvold, C. G., Larsen, T. S., Møller, M. B., Hansen, L. L., & Wojdacz, T. K. (2018) · Epigenomics · doi:10.2217/epi-2018-0020 · Cited by 6
Shen, Y., Xiong, W., Gu, Q., Zhang, Q., Yue, J., Liu, C., & Wang, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.654635 · Cited by 7
“Hypermethylation of the promoter region is a crucial process that can lead to epigenetic silencing of tumor suppressor genes (15, 16).”
BackgroundXie, T., Gorenjak, V., Stathopoulou, M. G., Dadé, S., Marouli, E., Masson, C., Murray, H. A., Lamont, J. V., FitzGerald, P. S., Deloukas, P., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01077-9 · Cited by 6
The Role of DNMT3B Mutations in the Pathogenesis of ICF Syndrome
Gatto, S., D’Esposito, M., & Matarazzo, M. R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3_2 · Cited by 6
Alpoim‐Moreira, J., Szóstek-Mioduchowska, A. Z., Słyszewska, M., Rebordão, M. R., Skarzynski, D. J., & Ferreira-Dias, G. M. (2023) · Animals · doi:10.3390/ani13071212 · Cited by 10
“In summary, although epigenetic alterations have been implicated in the development of many types of cancer [76,77], the role of epigenetic changes in fibrosis, particularly in equine endometrial fibrosis, needs much further investigation, since this research is relatively preliminary.”
BackgroundWang, H., & Luo, Y. (2023) · Journal of Engineering Research · doi:10.1016/j.jer.2023.09.010 · Cited by 7
Epigenetic Impact of Bioactive Dietary Compounds in Cancer Chemoprevention
Šupić, G., Wagner, D. O., & Magić, Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-21461-0_7 · Cited by 6
“Patterns of tumor suppressor gene hypermethylation show tumor-type specificity (Esteller 2007).”
BackgroundEpigenetic Mechanisms in Cancer Development
Martín-Subero, J. I., & Esteller, M. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_16 · Cited by 7
Young, M. A., May, S., Damo, A., Yoon, Y. S., Hur, M., Swat, W., & Parry, L. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0280 · Cited by 7
“org Mol Cancer Res; 17(3) March 2019 691”
BackgroundInfluentialReview and Prospect of Tissue-agnostic Targeted Strategies in Anticancer Therapies
Peng, Y., Tao, H., Gao, Y., Yang, Y., & Chen, Z. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200616143247 · Cited by 6
Mechanotransduction to Epigenetic Remodeling
Kelkhoff, D. O., Downing, T. L., & Li, S. (2016) · Springer eBooks · doi:10.1007/978-1-4939-5617-3_8 · Cited by 6
Juergens, U. R., Jäger, F., Darlath, W., Stöber, M., Vetter, H., & Gillissen, A. (2004) · PubMed · Cited by 8
Techniques/Tools to Study Epigenetic Biomarkers in Human Cancer Detection
Kumar, V., Singh, A., Gautam, P., & Sachan, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-3705-5_14 · Cited by 6
COSMC expression as a predictor of remission in IgA nephropathy
Akgül, S. U., Çınar, Ç. K., Çalışkan, Y., Demir, E., Cebeci, E., Meral, R., Temurhan, S., Özlük, Y., Aydın, F., & Oğuz, F. S. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03376-1 · Cited by 5
“In order to calculate the percentage of methylated (M) DNA, threshold cycle (Ct) value was put into a quantization algorithm provided by the manufacturer (Qiagen, Hilden, Germany) in an Excel macrospreadsheet format [13].”
MethodKorshoj, L. E., & Nagpal, P. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12568 · Cited by 4
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.